Related Experiment Video
Updated: Jun 5, 2026

11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
7-day longitudinal proteomics of critically ill patients: a pilot study
Anastasia N Sveshnikova1,2,3, Ivan O Butenko4, Liubov A Davydova5,6
1SBM Research Institute of Rospotrebnadzor, Moscow, Russia. a.sveshnikova@physics.msu.ru.
Scientific Reports
|June 3, 2026
Summary
Plasma proteome in intensive care unit (ICU) patients shows stability over seven days. Despite varied clinical parameters, individual patient protein profiles remained consistent, indicating limited short-term proteome dynamics in this pilot study.
Area of Science:
- Proteomics
- Clinical Biochemistry
- Intensive Care Medicine
Background:
- Adult health parameters exhibit stability, typically with <20% variability, barring circadian rhythms.
- Understanding proteome stability is crucial for interpreting biomarker fluctuations in critical care.
Purpose of the Study:
- To investigate the stability of the plasma proteome in intensive care unit (ICU) patients.
- To assess short-term proteome dynamics in relation to clinical parameter heterogeneity.
Main Methods:
- Prospective, observational pilot study involving bottom-up proteomics of blood plasma from adult ICU patients.
- Analysis of 8 week-long batches from 7 patients using MaxQuant software and custom R/Python scripts.
- Statistical analysis including random-effects modeling and Z-score-based hierarchical clustering.
Main Results:
- 218 proteins identified, with 68 consistently detected across all patient samples.
- Most proteins exhibited within-patient variance <30%, with time effects on variance <5%.
- Hierarchical clustering demonstrated patient-specific proteome profiles that remained stable over the observation period.
Conclusions:
- The plasma proteome of ICU patients exhibits individual characteristics and stability over a seven-day period.
- Short-term proteome dynamics were not evident in this pilot cohort, suggesting limited value for daily proteome analysis in this context.
